Trial Profile
Open Label Multi-center Pilot Phase I/II Non-controlled Clinical Trial to Assess Safety and Efficieecy of the Lenalidomide and Dexamethasone Association in Patients With Chronic Relapse or Treatment Resistant Lymphatic Leukemia Following Treatment Containing Fludarabine
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 11 Feb 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Dec 2010 New trial record